BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tiainen S, Masarwah A, Oikari S, Rilla K, Hämäläinen K, Sudah M, Sutela A, Vanninen R, Ikonen J, Tammi R, Tammi M, Auvinen P. Tumor microenvironment and breast cancer survival: combined effects of breast fat, M2 macrophages and hyaluronan create a dismal prognosis. Breast Cancer Res Treat 2020;179:565-75. [PMID: 31720917 DOI: 10.1007/s10549-019-05491-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Yadav NVS, Barcikowski A, Uehana Y, Jacobs AT, Connelly L. Breast Adipocyte Co-culture Increases the Expression of Pro-angiogenic Factors in Macrophages. Front Oncol 2020;10:454. [PMID: 32318345 DOI: 10.3389/fonc.2020.00454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
2 Mehraj U, Ganai RA, Macha MA, Hamid A, Zargar MA, Bhat AA, Nasser MW, Haris M, Batra SK, Alshehri B, Al-Baradie RS, Mir MA, Wani NA. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities. Cell Oncol (Dordr) 2021. [PMID: 34528143 DOI: 10.1007/s13402-021-00634-9] [Reference Citation Analysis]
3 Lin L, Kuhn C, Ditsch N, Kolben T, Czogalla B, Beyer S, Trillsch F, Schmoeckel E, Mayr D, Mahner S, Jeschke U, Hester A. Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs). Breast Cancer Res 2021;23:45. [PMID: 33849622 DOI: 10.1186/s13058-021-01422-x] [Reference Citation Analysis]
4 Skytthe MK, Graversen JH, Moestrup SK. Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases. Int J Mol Sci 2020;21:E5497. [PMID: 32752088 DOI: 10.3390/ijms21155497] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
5 Li Y, Miao W, He D, Wang S, Lou J, Jiang Y, Wang S. Recent Progress on Immunotherapy for Breast Cancer: Tumor Microenvironment, Nanotechnology and More. Front Bioeng Biotechnol 2021;9:680315. [PMID: 34150736 DOI: 10.3389/fbioe.2021.680315] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Guo L, Jing Y. Construction and Identification of a Novel 5-Gene Signature for Predicting the Prognosis in Breast Cancer. Front Med (Lausanne) 2021;8:669931. [PMID: 34722557 DOI: 10.3389/fmed.2021.669931] [Reference Citation Analysis]
7 Hillers-Ziemer LE, Kuziel G, Williams AE, Moore BN, Arendt LM. Breast cancer microenvironment and obesity: challenges for therapy. Cancer Metastasis Rev 2022. [PMID: 35435599 DOI: 10.1007/s10555-022-10031-9] [Reference Citation Analysis]
8 Xing Q, Feng Y, Sun H, Yang S, Sun T, Guo X, Ji F, Wu B, Zhou D. Scavenger receptor MARCO contributes to macrophage phagocytosis and clearance of tumor cells. Exp Cell Res 2021;408:112862. [PMID: 34626585 DOI: 10.1016/j.yexcr.2021.112862] [Reference Citation Analysis]
9 Zhao Y, Zhang B, Zhang Q, Ma X, Feng H. Tumor-associated macrophages in osteosarcoma. J Zhejiang Univ Sci B 2021;22:885-92. [PMID: 34783219 DOI: 10.1631/jzus.B2100029] [Reference Citation Analysis]
10 Su S, Xie R, Ding X, Lin Y. Three Cases of Bilateral Breast Absence Associated with Familial Congenital Ectodermal Defects. Clin Cosmet Investig Dermatol 2021;14:377-83. [PMID: 33883917 DOI: 10.2147/CCID.S300010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhang J, Hou C, Dou S, Li G, Wang Z, Liu Y, Zhang Y, Wang R, Shen B, Han G. T cell immunoglobulin and mucin domain protein 3 inhibits glycolysis in RAW 264.7 macrophages through Hexokinase 2. Scand J Immunol 2021;93:e12981. [PMID: 33031600 DOI: 10.1111/sji.12981] [Reference Citation Analysis]
12 Feng C, Xiong Z, Wang C, Xiao W, Xiao H, Xie K, Chen K, Liang H, Zhang X, Yang H. Folic acid-modified Exosome-PH20 enhances the efficiency of therapy via modulation of the tumor microenvironment and directly inhibits tumor cell metastasis. Bioact Mater 2021;6:963-74. [PMID: 33102939 DOI: 10.1016/j.bioactmat.2020.09.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
13 Zou R, Gu R, Yu X, Hu Y, Yu J, Xue X, Zhu X. Characteristics of Infiltrating Immune Cells and a Predictive Immune Model for Cervical Cancer. J Cancer 2021;12:3501-14. [PMID: 33995627 DOI: 10.7150/jca.55970] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Witschen PM, Chaffee TS, Brady NJ, Huggins DN, Knutson TP, LaRue RS, Munro SA, Tiegs L, McCarthy JB, Nelson AC, Schwertfeger KL. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. Cancers (Basel) 2020;12:E1325. [PMID: 32455980 DOI: 10.3390/cancers12051325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Deng Y, Hu JC, He SH, Lou B, Ding TB, Yang JT, Mo MG, Ye DY, Zhou L, Jiang XC, Yu K, Dong JB. Sphingomyelin synthase 2 facilitates M2-like macrophage polarization and tumor progression in a mouse model of triple-negative breast cancer. Acta Pharmacol Sin 2021;42:149-59. [PMID: 32451413 DOI: 10.1038/s41401-020-0419-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
16 Chen H, Tang C, Tan C, Wu F, Li Z, Ji W, Lu L, Xu C, Shen Z, Huang Y, Ding X. IL-2 Modulates TAMs Derived Exosomal MiRNAs to Ameliorate Hepatocellular Carcinoma Development and Progression. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/3445350] [Reference Citation Analysis]